Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings
about
Antiretroviral drugs-based HIV prevention methods: what impact on the HIV epidemic?Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challengesHIV treatment as prevention: contradictory perspectives from dynamic mathematical modelsPre-exposure prophylaxis of HIVPrevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovirSystemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT miceFactors influencing the emergence and spread of HIV drug resistance arising from rollout of antiretroviral pre-exposure prophylaxis (PrEP)Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational studyThe potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling studyThe cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studiesRectal transmission of transmitted/founder HIV-1 is efficiently prevented by topical 1% tenofovir in BLT humanized miceAnalytic review of modeling studies of ARV Based PrEP interventions reveals strong influence of drug-resistance assumptions on the population-level effectivenessPre-exposure prophylaxis for the prevention of HIV infection in high risk populations: a meta-analysis of randomized controlled trialsHow Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts' Opinion and Its Influence on the Projected Public Health ImpactHIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisalWhere to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?Antiretroviral therapy for prevention of HIV infection: new clues from an animal model.The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study.Development, calibration and performance of an HIV transmission model incorporating natural history and behavioral patterns: application in South Africa.Evaluating the cost-effectiveness of pre-exposure prophylaxis (PrEP) and its impact on HIV-1 transmission in South AfricaOral pre-exposure prophylaxis by anti-retrovirals raltegravir and maraviroc protects against HIV-1 vaginal transmission in a humanized mouse model.HIV transmission networks.ARV-based HIV prevention for women - where we are in 2014.Comparability of results from pair and classical model formulations for different sexually transmitted infections.Implementation science of pre-exposure prophylaxis: preparing for public use.Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infectionAmbiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study.Impact of high-risk sex and focused interventions in heterosexual HIV epidemics: a systematic review of mathematical modelsA model of HIV drug resistance driven by heterogeneities in host immunity and adherence patterns.Packaging PrEP to Prevent HIV: An Integrated Framework to Plan for Pre-Exposure Prophylaxis Implementation in Clinical PracticeAlcohol use and HIV serostatus of partner predict high-risk sexual behavior among patients receiving antiretroviral therapy in South Western Uganda.Pre-exposure prophylaxis and the promise of combination prevention approachesRethinking prevention of HIV type 1 infection.Chemoprophylaxis for HIV prevention: new opportunities and new questions.Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations.Pre-exposure prophylaxis of HIV: A right way to go or a long way to go?Abriendo Puertas: baseline findings from an integrated intervention to promote prevention, treatment and care among FSW living with HIV in the Dominican RepublicIndices to measure risk of HIV acquisition in Rakai, Uganda.Nuclear receptor signaling inhibits HIV-1 replication in macrophages through multiple trans-repression mechanismsTargeting pre-exposure prophylaxis among men who have sex with men in the United States and Peru: partnership types, contact rates, and sexual role.
P2860
Q26825761-B6A184CB-70CD-4D91-8A0D-3C9DF7898F29Q27023352-1B61BBDD-2EAC-49E2-B692-C72026E83B23Q28080917-860A2EFA-AB98-40BC-B323-8A0BD221233EQ28244364-830BE04F-9CF4-4C1D-9712-988650EC5AA5Q28472146-DBB2F780-51A9-444D-A359-AF97954482AEQ28472590-4385930B-7A70-470E-9AF5-354BFADF80D5Q28477780-2DC9878B-F806-450F-997F-06C6C39315DEQ28478776-025CA1B6-91E1-4A22-A237-A96F1489425AQ28484308-BAE82A53-64AF-42E9-8C80-68C61AD4D23CQ28487926-7894600F-650C-46F0-AC9C-E11F1E917071Q28488527-282D0E9A-04CB-4276-BAB6-B3B0ED01BE78Q28535414-22B2DE41-33DB-4AF9-A6CE-134D4913F4FDQ28539443-D1AF857B-1325-4072-B2CA-7556F3A146A3Q28552455-33D47370-FA1C-4E0D-8EAD-79F453CC6508Q28741736-5BA3CD10-7B03-4E8C-8DA3-3CE80D7F39E6Q30352591-3EF717B4-429F-47E5-9557-F571B3D8A38CQ33318541-B0C4E4E4-7CA6-405D-8AB7-765CAC303D7DQ33332191-5676F84F-25CB-4879-9C22-265A62153CD9Q33670446-6BCCA4F8-7EDB-4C22-B789-F0D8BE0FA37DQ33747742-A9BA13AB-84AC-4B4A-B175-324CC6AEE285Q33784852-A3EE7445-3F08-4251-A47F-514DBAF43FF7Q33908509-E1EC7E9E-0D73-407E-BB33-82A875227E51Q34180729-70D768FC-4411-48CA-92F7-44CA16AFD81AQ34326273-AC1E692F-4DE5-43D3-9836-B89AFDBD9164Q34448430-05E14B2C-B58B-47AF-BE8A-0BC0D09EED2BQ34481359-FE4686C6-B4C8-4629-BE24-B594FA693CC5Q34482984-FF8F3D00-4FD3-483B-A8CB-FA0111306FD4Q34505770-2A3DA4EF-BA93-4CB3-A2E7-2A3F11F1AC9FQ34573789-BACAC4F3-AEC3-47B9-A15A-BD7BC5A85BB2Q34680992-27CA5E11-3FC7-46EA-A5D9-EDA1258516A7Q34704509-E7E2F5E7-68F5-4ADC-A7C6-22CAB805F244Q34724603-3A3C0934-8B54-4175-B252-FB2A895356C4Q34767070-20D2C306-2C82-4138-BC05-9657935F6143Q34786284-38268F44-0A26-4A85-8FDE-B0A171FDBB9BQ34989216-3BEDC2FB-153F-40DE-8C13-05305C11BCE1Q35033732-3634F1F1-ACE5-4C5A-B65B-E9D709A1CE71Q35097322-4104A2DA-50B8-48DD-96E7-A3BAC87C9289Q35139980-ED8ACA98-C017-49F4-98E6-9A4FA53A5386Q35274791-17F3223A-18C1-4216-9625-4DDF052D678AQ35575958-218F00B9-4273-485B-9702-2C1D9CBF2E56
P2860
Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Potential impact of antiretrov ...... n in resource-limited settings
@ast
Potential impact of antiretrov ...... n in resource-limited settings
@en
Potential impact of antiretrov ...... in resource-limited settings.
@nl
type
label
Potential impact of antiretrov ...... n in resource-limited settings
@ast
Potential impact of antiretrov ...... n in resource-limited settings
@en
Potential impact of antiretrov ...... in resource-limited settings.
@nl
prefLabel
Potential impact of antiretrov ...... n in resource-limited settings
@ast
Potential impact of antiretrov ...... n in resource-limited settings
@en
Potential impact of antiretrov ...... in resource-limited settings.
@nl
P2860
P1433
P1476
Potential impact of antiretrov ...... n in resource-limited settings
@en
P2093
John W Mellors
Ume L Abbas
P2860
P356
10.1371/JOURNAL.PONE.0000875
P407
P577
2007-09-19T00:00:00Z